1. Effects of PCSK-9 Inhibition by Alirocumab Treatments on Biliary Cirrhotic Rats
   Hui-Chun Huang et al, 2022, International Journal of Molecular Sciences CrossRef
2. Evaluation of the possible nephroprotective effects of vitamin E and rosuvastatin in amikacin‐induced renal injury in rats
   Ahmed Selim et al, 2017, Journal of Biochemical and Molecular Toxicology CrossRef
3. The impact of dyslipidemia and oxidative stress on vasoactive mediators in patients with renal dysfunction
   Maryam Jabarpour et al, 2019, International Urology and Nephrology CrossRef
4. HYPOLIPIDEMIC EFFICACY OF ZINGIBER OFFICINALE EXTRACT IN COMPARISON WITH FENOFIBRATE, ROSUVASTATIN AND EZETIMIBE IN HYPERLIPIDEMIC RATS
   Kawa Dizaye et al, 2019, JOURNAL OF SULAIMANI MEDICAL COLLEGE CrossRef
5. Rosuvastatin improves olanzapine’s effects on behavioral impairment and hippocampal, hepatic and metabolic damages in isolated reared male rats
   Aya Mohammed et al, 2020, Behavioural Brain Research CrossRef